Use of Activated Protein C in Liver Transplantation Patients with Septic Shock (vol 14, pg 1598, 2008)

被引:0
|
作者
Rinaldi, L.
Marietta, M.
Mignini, M. A.
Busani, S.
Codeluppi, M.
Masetti, M.
机构
[1] Univ Modena & Reggio Emilia, Dept Anaesthesiol, Modena, Italy
[2] Univ Modena & Reggio Emilia, Intens Care Unit, Modena, Italy
[3] Univ Modena & Reggio Emilia, Dept Haematol, Modena, Italy
[4] Univ Hosp Modena, Dept Anaesthesiol, Modena, Italy
[5] Univ Hosp Modena, Intens Care Unit, Modena, Italy
[6] Univ Hosp Modena, Dept Haematol, Modena, Italy
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:119 / 119
页数:1
相关论文
共 50 条
  • [21] Activated protein C in septic shock: a propensity-matched analysis
    Farid Sadaka
    Jacklyn O'Brien
    Matthew Migneron
    Julie Stortz
    Alexander Vanston
    Robert W Taylor
    Critical Care, 15
  • [22] ACTIVATED PROTEIN C IN SEPTIC SHOCK: A PROPENSITY-MATCHED ANALYSIS
    Sadaka, Farid
    O'Brien, Jacklyn
    Migneron, Matthew
    Stortz, Julie
    Vanston, Alexander
    Taylor, Robert
    CRITICAL CARE MEDICINE, 2010, 38 (12) : U24 - U24
  • [23] Pasteurella multocida septic shock following liver transplantation treated with drotrecogin alfa (activated)
    Al-Sabah, S.
    Goldberg, P.
    Qureshi, S. T.
    TRANSPLANT INFECTIOUS DISEASE, 2007, 9 (03) : 233 - 243
  • [24] Metabolic liver disease in children (vol 14, pg 391, 2008)
    Hansen, Kelli
    Horslen, Simon
    LIVER TRANSPLANTATION, 2008, 14 (05) : 713 - 733
  • [25] BENEFICIAL OUTCOME EFFECT OF ACTIVATED PROTEIN C IN PATIENTS WITH SEPTIC SHOCK: A CASE-MATCHING STUDY
    Teboul, J. -L.
    Aegerter, P.
    Monnet, X.
    Ksouri, H.
    Martel, P.
    Richard, C.
    Guidet, B.
    INTENSIVE CARE MEDICINE, 2009, 35 : 239 - 239
  • [26] Predictors of 28-day Mortality in Patients undergoing treatment with Activated Protein C for Septic Shock
    Duggal, A.
    Zaaqoq, A. M.
    Waraich, K. K.
    Nseir, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [27] Editors’ comments on a new trial of activated protein C for persistent septic shock
    Jordi Mancebo
    Massimo Antonelli
    Intensive Care Medicine, 2008, 34 : 1948 - 1949
  • [28] Activated protein C consumption and coagulation parameters in severe sepsis and septic shock
    M De La Torre-Prados
    A Garcia-de la Torre
    C Trujillano-Fernandez
    J Perez-Vacas
    A Puerto-Morlan
    E Camara-Sola
    Critical Care, 18 (Suppl 1):
  • [29] Current role of activated protein C therapy for severe sepsis and septic shock
    Barie P.S.
    Current Infectious Disease Reports, 2008, 10 (5) : 368 - 376
  • [30] MicroRNA expression following activated protein C treatment during septic shock
    Moore, Cathy C.
    McKillop, Iain H.
    Toan Huynh
    JOURNAL OF SURGICAL RESEARCH, 2013, 182 (01) : 116 - 126